Sam Bankman-Fried’s bail revoked as federal judge orders FTX founder to jail

FAN Editor

A federal judge revoked FTX founder Sam Bankman-Fried’s bail during a hearing on Friday, thereby ordering him to jail.

U.S. District Judge Lewis A. Kaplan revoked Bankman-Fried’s bail after prosecutors argued that the FTX founder attempted to harass a key witness in the case.

CLICK HERE TO READ MORE ON FOX BUSINESS

Bankman-Fried has been under house arrest in California since his December extradition from the Bahamas.

He pled not guilty to stealing billions in FTX customer funds to plug losses at his hedge fund Alameda Research. Bankman-Fried has been largely confined to his parents’ Palo Alto, California, home. He avoided spending all the time in jail until his trial after posting a $250 million bond since his December 2022 arrest.

Prosecutors alleged the former billionaire “crossed a line” by sharing the personal writings of ex-girlfriend Caroline Ellison with a New York Times reporter.

Ellison — Alameda’s former CEO — is expected to testify against Bankman-Fried after pleading guilty to fraud and agreeing to cooperate with prosecutors.

Bankman-Fried’s attorneys argued that prosecutors mischaracterized his intentions in sharing Ellison’s writings. 

“In support of its theory that Mr. Bankman-Fried ‘tampered’ with witnesses, the Government proffers evidence that consists of innuendo, speculation and scant facts,” the lawyers wrote, according to The Associated Press. “The Government’s showing is a far cry from the evidence presented in cases in this district where remand has been ordered in connection with alleged witness tampering, and in no way supports revocation of Mr. Bankman-Fried’s bail.”

The Associated Press contributed to this report.

Free America Network Articles

Leave a Reply

Next Post

SEC investigating Illumina over acquisition of cancer test developer Grail

A building on the campus at the world headquarters of Illumina is shown in San Diego, California, Sept. 1, 2021. Mike Blake | Reuters The U.S. Securities and Exchange Commission is investigating Illumina over its controversial $7.1 billion acquisition of cancer test developer Grail, the DNA sequencing company said in […]

You May Like